Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

THE TRUTH ABOUT: 53 | History Defined

RFK Jr orders mifepristone review as anti-abortion groups push for ban

Health secretary cites ‘new data’ that emerged from flawed study conservatives are using to pressure US government

The Guardian - US · May 14, 2025

European court delivers blow to EU Commission over Von der Leyen-Pfizer texts

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission President Ursula von der Leyen and Pfizer’s CEO during the Covid-19 vaccine negotiations.

Radio France Internationale · May 14, 2025

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.

MarketBeat · May 14, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore

These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next

MarketBeat · May 14, 2025

Von der Leyen’s texts with Pfizer boss can be shared, says EU’s highest court

European court of justice says no ‘plausible explanation’ given for denying New York Times access to texts from pandemic

The Guardian - UK · May 14, 2025

RFK Jr. Admitting Big Pharma Paid Trump '$100 Million' Leaves Internet Stunned: 'Was That a Fraudian Slip?'

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

Latin Times · May 13, 2025

Europe's Biggest 'Green' Methanol Plant Opens In Denmark

Europe's largest "green" methanol plant opened in Denmark on Tuesday, boosting the continent's emissions reduction efforts -- with customers ranging from shipping giant Maersk to toymaker Lego and pharmaceutical firm Novo Nordisk.

International Business Times · May 13, 2025

Read news from The Economist, FT, and more,
with one subscription

Nationwide eye care product recall as experts warn to stop using this product immediately

More than 1.8 million units of this eye care solution have been recalled

Evening Standard · May 13, 2025

Trump signs order aiming to slash US drug prices to match those abroad

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges

The Guardian - US · May 12, 2025

Trump vows to cut drug prices by 59%, pharma stocks plummet

President Trump's unexpected drug price slash promise rocks global markets.

We Got This Covered · May 12, 2025

This serum is best-selling for a reason—it tackles everything from dryness to pigmentation, and costs less than £40

The ingredients lineup is impressive

Marie Claire · May 12, 2025

The Best Health Care Stocks to Buy

The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.

Kiplinger · May 8, 2025

3 Mid-Cap Medical Stocks Outperforming the Market

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

MarketBeat · May 6, 2025

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Shares of Eli Lilly just got walloped. So, is the company still the name to own in GLP-1s, or are the tables turning on this pharma giant?

MarketBeat · May 6, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · May 5, 2025

Americans would suffer most if Trump imposes pharma tariffs, sector warns

Industry says levies would hit supply chains, making medicines potentially unaffordable for some US patients

The Guardian - UK · May 2, 2025

Snake collector’s immunity quest opens path towards universal antivenom

Blood from man bitten hundreds of times by deadly snakes is used to create most broadly protective antivenom yet

MarketBeat · May 2, 2025

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

The Guardian - UK · May 1, 2025

Trump hints at tariff reprieve for pharma companies that bring operations back to US

He suggests drugmakers would get ‘a lot of time’ to repatriate manufacturing before facing levies

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Apr 30, 2025

Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors

A pharmaceutical company that paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million.

Evening Standard · Apr 30, 2025

Drugs giant GSK ‘well positioned’ to absorb potential US tariffs

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines.

The Independent UK · Apr 29, 2025

You might soon be able to get Wegovy from an online shop — here is where you need to visit

The move comes as Danish drugmaker Novo Nordisk has acted to slash the popular weight loss drug’s price

International Business Times · Apr 29, 2025

AstraZeneca Moves Some Production To US Amid Tariff Threat

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.

The Guardian - UK · Apr 29, 2025

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal Soriot

Evening Standard · Apr 29, 2025

AstraZeneca plots US expansion despite Trump tariff threat

The drug maker said it is ‘firmly committed to investing and growing in the US’ amid potential import tariffs on the pharmaceutical industry.

International Business Times UK · Apr 28, 2025

Moderna Faces Suspension After Offering UK Children £1,500 And Teddy Bears To Join COVID Trials

Moderna, known for its COVID-19 vaccines, has been found guilty of 10 breaches of regulatory code after it marketed its booster jab trials towards children.

1 … 52 53 54 55

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.